Cargando…
Correction: Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study
Autores principales: | Tőkés, Anna-Mária, Kulka, Janina, Paku, Sándor, Szik, Ágnes, Páska, Csilla, Novák, Pál Kaposi, Szilák, László, Kiss, András, Bögi, Krisztina, Schaff, Zsuzsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052986/ http://dx.doi.org/10.1186/bcr1265 |
Ejemplares similares
-
Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study
por: Tőkés, Anna-Mária, et al.
Publicado: (2005) -
Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors
por: Hajósi-Kalcakosz, Szofia, et al.
Publicado: (2012) -
Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases
por: Virág, József, et al.
Publicado: (2016) -
Addition of Chromosome 17 Polysomy and HER2 Amplification Status Improves the Accuracy of Clinicopathological Factor-Based Progression Risk Stratification and Tumor Grading of Non-Muscle-Invasive Bladder Cancer
por: Kocsmár, Ildikó, et al.
Publicado: (2022) -
Morphological and pathological response in primary systemic therapy of patients with breast cancer and the prediction of disease free survival: a single center observational study
por: Szentmártoni, Gyöngyvér, et al.
Publicado: (2016)